Ekadashi kab hai in 2026: Rama on Nov 5, Devutthana on Nov 20, Papankusha on Oct 22 
Navy Court-Martials Captain, Lieutenant Commander Over INS Brahmaputra Capsizing 
K.C. Bokadia recalls the stars who never billed producers for staff 
SSC CGL Tier 1 Answer Key 2026 Is a Challenge Window, Not a Result 
Nico Paz puts Como on Europe’s radar with a brace-less four-goal win, a Tenerife tribute and Premier League bidders sniffing 
Enables leading research university to validate electronic-photonic hybrid approach used to support tera bit per second data rates SANTA ROSA,...
HONG KONG--(BUSINESS WIRE)--AM Best has placed under review with negative implications the Financial Strength Rating of A (Excellent) and the...
HONG KONG--(BUSINESS WIRE)--#insurance--AM Best has placed under review with negative implications the Financial Strength Rating of A (Excellent) and the...
New Software Complements Renesas Leading Li-Ion Battery Manager IC to Enable ASIL D-Compliant Designs TOKYO, Japan--(BUSINESS WIRE)--#ASILD--Renesas Electronics Corporation (TSE:6723),...
Chuck Kenyon to Retire From HR Leadership Role after 18 Years Katherine Armstrong Senior Vice President of Human Resources for...
SAN FRANCISCO--(BUSINESS WIRE)--#agexpansion--Andersen Global continues to solidify its international presence as Andersen in Georgia (formerly Prime Tax LLC) debuts in...
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies...
SAN FRANCISCO--(BUSINESS WIRE)--#agexpansion--Andersen Global continues to solidify its international presence as Andersen in Georgia (formerly Prime Tax LLC) debuts in...
SAN FRANCISCO--(BUSINESS WIRE)--#agexpansion--Andersen Global continues to solidify its international presence as Andersen in Georgia (formerly Prime Tax LLC) debuts in...
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies...
Boehringer Ingelheim gains exclusive global rights to a panel of cancer-specific antibodies to enable the development of targeted cancer therapies...
SAN JOSE, Calif.--(BUSINESS WIRE)--Credo Technology Group Holding Ltd (NASDAQ: CRDO) today announced the availability of its Ostrich 40G, PAM3 Serializer/Deserializer...
Outlines Significant Growth Opportunities with Strong Momentum in Core Business and Adjacencies NEW YORK--(BUSINESS WIRE)--REA Group is targeting "double-digit revenue...
SAN JOSE, Calif.--(BUSINESS WIRE)--Credo Technology Group Holding Ltd (NASDAQ: CRDO) today announced the availability of its Ostrich 40G, PAM3 Serializer/Deserializer...
SAN JOSE, Calif.--(BUSINESS WIRE)--Credo Technology Group Holding Ltd (NASDAQ: CRDO) today announced the availability of its Ostrich 40G, PAM3 Serializer/Deserializer...
